Brina Medical Unveils CMAT Advantage for Enhanced Chronic Disease Detection

Brina Medical has launched the CMAT Advantage, a next-generation point-of-care diagnostic device aimed at accelerating chronic disease detection and transforming patient care, announced in a press release. The device is designed to integrate seamlessly into clinical workflows, providing real-time clinical insights that enable healthcare providers to detect diseases at their most manageable stages.

The CMAT Advantage leverages proprietary AI and precision-calibrated decision support tools to deliver accurate diagnostics, helping to reduce avoidable hospitalizations and accelerate clinical decisions. Brent Pearson, CEO of Brina Medical, emphasized the device's role in empowering care teams to act decisively and improve patient outcomes.

In addition to the product launch, Brina Medical has formed an Advisory Board to guide its domestic and global growth strategies. This board will focus on aligning the company's innovations with the evolving needs of hospital systems and healthcare providers.